Advertisement

Meeting Coverage

PhysQuiz Answers! SABCS 2020

1) In an updated analysis of the phase 2 DESTINY-Breast01 study, women with HER2-positive metastatic breast cancer ADC trastuzumab deruxtecan (Enhertu) continued to demonstrate favorable data, including a median progression-free...

Read More

PhysQuiz Answers! AAN 2021: Multiple Sclerosis

Which of the following is a preliminary outcome of the retrospective, multi-center observational study in a cohort of Italian MS patients investigating the impact of disease-modifying treatments on COVID-19 course of disease?a)...

Read More

Results from Phase 3 CLEAR Study for Advanced RRC

In patients with advanced RCC, second-line treatment with LEN + EVE prolonged progression-free survival (PFS) compared with EVE alone. LEN + PEMBRO, also showed preliminary efficacious evidence in a phase 1/2 RCC study. Here, we...

Read More
Advertisement